180 Wealth Advisors LLC Purchases 117 Shares of Tenet Healthcare Co. (NYSE:THC)

180 Wealth Advisors LLC increased its position in shares of Tenet Healthcare Co. (NYSE:THC) by 5.1% during the 4th quarter, Holdings Channel reports. The fund owned 2,414 shares of the company’s stock after buying an additional 117 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Tenet Healthcare were worth $305,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of THC. Choreo LLC bought a new position in Tenet Healthcare in the second quarter valued at approximately $335,000. American Century Companies Inc. lifted its stake in Tenet Healthcare by 28.9% in the second quarter. American Century Companies Inc. now owns 16,223 shares of the company’s stock valued at $2,158,000 after buying an additional 3,641 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Tenet Healthcare by 48.8% in the second quarter. DekaBank Deutsche Girozentrale now owns 4,119 shares of the company’s stock valued at $570,000 after buying an additional 1,351 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Tenet Healthcare by 67.1% in the second quarter. Envestnet Asset Management Inc. now owns 209,020 shares of the company’s stock valued at $27,806,000 after buying an additional 83,935 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new position in Tenet Healthcare in the second quarter valued at approximately $27,454,000. Institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $155.94, for a total value of $623,760.00. Following the completion of the sale, the executive vice president now owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.93% of the stock is currently owned by company insiders.

Tenet Healthcare Price Performance

NYSE:THC opened at $130.04 on Thursday. Tenet Healthcare Co. has a one year low of $78.03 and a one year high of $171.20. The company has a market cap of $12.37 billion, a P/E ratio of 4.17, a P/E/G ratio of 0.61 and a beta of 2.06. The firm’s fifty day moving average price is $139.72 and its two-hundred day moving average price is $148.18. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.93 EPS for the quarter, beating the consensus estimate of $2.33 by $0.60. The firm had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.05 billion. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.44 earnings per share. Equities analysts expect that Tenet Healthcare Co. will post 11.38 earnings per share for the current year.

Analysts Set New Price Targets

THC has been the topic of a number of research reports. Cantor Fitzgerald lifted their price target on shares of Tenet Healthcare from $168.00 to $177.00 and gave the company an “overweight” rating in a research note on Wednesday, October 30th. UBS Group lifted their price objective on shares of Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Royal Bank of Canada lifted their price objective on shares of Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a report on Friday, November 22nd. Finally, StockNews.com downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 17th. Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $165.00.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.